Kyoto University Graduate School of Medicine*, one of Asia’s leading research-oriented institutions, has recently chosen Intel® Xeon® Scalable processors to power its clinical genome analysis cluster and its molecular simulation cluster. These clusters will aid in Kyoto’s search for new drug discoveries and help reduce research and development costs.
The Intel Xeon Scalable platform offers potent performance for all types of artificial intelligence (AI). Intel’s optimizations for popular deep learning frameworks have produced up to 127 times1 performance gains for deep learning training and 198 times2 performance gains for deep learning inference for AI workloads running on Intel Xeon Scalable processors. Kyoto is one of many leading healthcare providers and research institutions that are working with Intel and using Intel artificial intelligence technology to tackle some of the biggest challenges in healthcare.
